Cargando…
Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier
BACKGROUND: Glaucoma is a serious eye disease that can lead to loss of vision. Unfortunately, effective treatments are limited by poor bioavailability of antiglaucoma medicine due to short residence time on the preocular surface. MATERIALS AND METHODS: To solve this, we successfully prepared novel c...
Autores principales: | Tian, Shuangyan, Li, Juan, Tao, Qi, Zhao, Yawen, Lv, Zhufen, Yang, Fan, Duan, Haoyun, Chen, Yanzhong, Zhou, Qingjun, Hou, Dongzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769559/ https://www.ncbi.nlm.nih.gov/pubmed/29391798 http://dx.doi.org/10.2147/IJN.S146346 |
Ejemplares similares
-
Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
por: Liu, Shuo, et al.
Publicado: (2020) -
A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride
por: Huang, Yi, et al.
Publicado: (2017) -
Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
por: Li, Juan, et al.
Publicado: (2018) -
Eudragit(®) L100/N-Trimethylchitosan Chloride Microspheres for Oral Insulin Delivery
por: Marais, Etienne, et al.
Publicado: (2013) -
Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone
por: Ban, Junfeng, et al.
Publicado: (2017)